\BOOKMARK [0][-]{titelblad.0}{Titelblad}{}% 1
\BOOKMARK [0][-]{chapter.1}{Introduktion}{}% 2
\BOOKMARK [1][-]{section.1.1}{Indledning}{chapter.1}% 3
\BOOKMARK [1][-]{section.1.2}{Initierende problemstilling}{chapter.1}% 4
\BOOKMARK [0][-]{chapter.2}{Metode}{}% 5
\BOOKMARK [1][-]{section.2.1}{Projektets metode}{chapter.2}% 6
\BOOKMARK [2][-]{subsection.2.1.1}{Argumentation for valg af dom\346ner}{section.2.1}% 7
\BOOKMARK [2][-]{subsection.2.1.2}{Litteraturs\370gning}{section.2.1}% 8
\BOOKMARK [0][-]{chapter.3}{Problemanalyse}{}% 9
\BOOKMARK [1][-]{section.3.1}{Patientforl\370b}{chapter.3}% 10
\BOOKMARK [2][-]{subsection.3.1.1}{Behandling}{section.3.1}% 11
\BOOKMARK [2][-]{subsection.3.1.2}{Postoperative TKA-resultater}{section.3.1}% 12
\BOOKMARK [1][-]{section.3.2}{Behandlingsmetoder}{chapter.3}% 13
\BOOKMARK [2][-]{subsection.3.2.1}{Kn\346leddet}{section.3.2}% 14
\BOOKMARK [2][-]{subsection.3.2.2}{Kn\346artrose}{section.3.2}% 15
\BOOKMARK [2][-]{subsection.3.2.3}{Non-invasiv behandling}{section.3.2}% 16
\BOOKMARK [2][-]{subsection.3.2.4}{Kirurgisk behandling}{section.3.2}% 17
\BOOKMARK [1][-]{section.3.3}{Smerte}{chapter.3}% 18
\BOOKMARK [2][-]{subsection.3.3.1}{Anatomi og fysiologi}{section.3.3}% 19
\BOOKMARK [2][-]{subsection.3.3.2}{Smertetyper}{section.3.3}% 20
\BOOKMARK [2][-]{subsection.3.3.3}{Smerte og kn\346artrose}{section.3.3}% 21
\BOOKMARK [1][-]{section.3.4}{Klinisk udv\346lgelse af patienter}{chapter.3}% 22
\BOOKMARK [1][-]{section.3.5}{Teknologier til smerteklassificering}{chapter.3}% 23
\BOOKMARK [2][-]{subsection.3.5.1}{Functional Magnetic Resonance Imaging}{section.3.5}% 24
\BOOKMARK [2][-]{subsection.3.5.2}{Quantitative sensory testing}{section.3.5}% 25
\BOOKMARK [2][-]{subsection.3.5.3}{Elektrofysiologiske unders\370gelsesmetoder}{section.3.5}% 26
\BOOKMARK [2][-]{subsection.3.5.4}{Vurdering af teknologier til smerteklassificering}{section.3.5}% 27
\BOOKMARK [0][-]{chapter.4}{Problemafgr\346nsning}{}% 28
\BOOKMARK [1][-]{section.4.1}{Problemafgr\346nsning}{chapter.4}% 29
\BOOKMARK [2][-]{subsection.4.1.1}{Problemformulering}{section.4.1}% 30
\BOOKMARK [0][-]{chapter.5}{Beskrivelse og tekniske karakteristika for teknologien \(TEC\)}{}% 31
\BOOKMARK [1][-]{section.5.1}{Form\345l}{chapter.5}% 32
\BOOKMARK [1][-]{section.5.2}{HTA sp\370rgsm\345l}{chapter.5}% 33
\BOOKMARK [1][-]{section.5.3}{Metode}{chapter.5}% 34
\BOOKMARK [1][-]{section.5.4}{Teknologiens egenskaber}{chapter.5}% 35
\BOOKMARK [2][-]{subsection.5.4.1}{Anvendelsesomr\345de for QST}{section.5.4}% 36
\BOOKMARK [2][-]{subsection.5.4.2}{Unders\370gelse af PPT, TSP og CPM}{section.5.4}% 37
\BOOKMARK [1][-]{section.5.5}{Teknologiens begr\346nsninger}{chapter.5}% 38
\BOOKMARK [2][-]{subsection.5.5.1}{Begr\346nsende faktorer ved benyttelse af QST}{section.5.5}% 39
\BOOKMARK [1][-]{section.5.6}{Sammenligning med nuv\346rende metoder}{chapter.5}% 40
\BOOKMARK [2][-]{subsection.5.6.1}{Sammenspil mellem QST og klinisk vurdering}{section.5.6}% 41
\BOOKMARK [1][-]{section.5.7}{Delkonklusion}{chapter.5}% 42
\BOOKMARK [0][-]{chapter.6}{Klinisk effekt \(EFF\)}{}% 43
\BOOKMARK [1][-]{section.6.1}{Form\345l}{chapter.6}% 44
\BOOKMARK [1][-]{section.6.2}{HTA sp\370rgsm\345l}{chapter.6}% 45
\BOOKMARK [1][-]{section.6.3}{Metode}{chapter.6}% 46
\BOOKMARK [1][-]{section.6.4}{Statistisk effekt}{chapter.6}% 47
\BOOKMARK [2][-]{subsection.6.4.1}{QST-protokollens statistiske styrke}{section.6.4}% 48
\BOOKMARK [1][-]{section.6.5}{N\370jagtighed}{chapter.6}% 49
\BOOKMARK [2][-]{subsection.6.5.1}{Patientgruppering p\345 baggrund af QST-resultater}{section.6.5}% 50
\BOOKMARK [2][-]{subsection.6.5.2}{Repeterbarhed for QST-protokollen}{section.6.5}% 51
\BOOKMARK [1][-]{section.6.6}{Delkonklusion}{chapter.6}% 52
\BOOKMARK [0][-]{chapter.7}{Sikkerhed \(SAF\)}{}% 53
\BOOKMARK [1][-]{section.7.1}{Form\345l}{chapter.7}% 54
\BOOKMARK [1][-]{section.7.2}{HTA sp\370rgsm\345l}{chapter.7}% 55
\BOOKMARK [1][-]{section.7.3}{Metode}{chapter.7}% 56
\BOOKMARK [1][-]{section.7.4}{Patientsikkerhed}{chapter.7}% 57
\BOOKMARK [2][-]{subsection.7.4.1}{Sikkerhedsm\346ssige risici for patienter}{section.7.4}% 58
\BOOKMARK [1][-]{section.7.5}{Sikkerhedsforanstaltninger}{chapter.7}% 59
\BOOKMARK [1][-]{section.7.6}{Delkonklusion}{chapter.7}% 60
\BOOKMARK [0][-]{chapter.8}{Organisatoriske aspekter \(ORG\)}{}% 61
\BOOKMARK [1][-]{section.8.1}{Form\345l}{chapter.8}% 62
\BOOKMARK [1][-]{section.8.2}{HTA sp\370rgsm\345l}{chapter.8}% 63
\BOOKMARK [1][-]{section.8.3}{Metode}{chapter.8}% 64
\BOOKMARK [1][-]{section.8.4}{Organisatoriske \346ndringer}{chapter.8}% 65
\BOOKMARK [2][-]{subsection.8.4.1}{Nuv\346rende behandlingsforl\370b for TKA-patienter}{section.8.4}% 66
\BOOKMARK [2][-]{subsection.8.4.2}{Behandlingsforl\370b ved implementering af QST-protokollen}{section.8.4}% 67
\BOOKMARK [2][-]{subsection.8.4.3}{Korrekt anvendelse af QST-protokollen}{section.8.4}% 68
\BOOKMARK [1][-]{section.8.5}{Opl\346ring og vedligeholdelse}{chapter.8}% 69
\BOOKMARK [2][-]{subsection.8.5.1}{Efteruddannelse}{section.8.5}% 70
\BOOKMARK [2][-]{subsection.8.5.2}{Vedligeholdelse af udstyr}{section.8.5}% 71
\BOOKMARK [1][-]{section.8.6}{Delkonklusion}{chapter.8}% 72
\BOOKMARK [0][-]{chapter.9}{Patient- og sociale aspekter \(SOC\)}{}% 73
\BOOKMARK [1][-]{section.9.1}{Form\345l}{chapter.9}% 74
\BOOKMARK [1][-]{section.9.2}{HTA sp\370rgsm\345l}{chapter.9}% 75
\BOOKMARK [1][-]{section.9.3}{Metode}{chapter.9}% 76
\BOOKMARK [1][-]{section.9.4}{Teknologiens p\345virkning p\345 patienten}{chapter.9}% 77
\BOOKMARK [2][-]{subsection.9.4.1}{Eksklusion af patienter}{section.9.4}% 78
\BOOKMARK [2][-]{subsection.9.4.2}{Betydning af QST-protokollen for patienten}{section.9.4}% 79
\BOOKMARK [1][-]{section.9.5}{Delkonklusion}{chapter.9}% 80
\BOOKMARK [0][-]{chapter.10}{Etik \(ETH\)}{}% 81
\BOOKMARK [1][-]{section.10.1}{Form\345l}{chapter.10}% 82
\BOOKMARK [1][-]{section.10.2}{HTA sp\370rgsm\345l}{chapter.10}% 83
\BOOKMARK [1][-]{section.10.3}{Metode}{chapter.10}% 84
\BOOKMARK [1][-]{section.10.4}{Patientetik}{chapter.10}% 85
\BOOKMARK [1][-]{section.10.5}{Delkonklusion}{chapter.10}% 86
\BOOKMARK [0][-]{chapter.11}{Omkostninger og \370konomisk evaluering \(ECO\)}{}% 87
\BOOKMARK [1][-]{section.11.1}{Form\345l}{chapter.11}% 88
\BOOKMARK [1][-]{section.11.2}{HTA sp\370rgsm\345l}{chapter.11}% 89
\BOOKMARK [1][-]{section.11.3}{Metode}{chapter.11}% 90
\BOOKMARK [2][-]{subsection.11.3.1}{Tilegnelse af \370konomisk viden om QST-protokollen}{section.11.3}% 91
\BOOKMARK [1][-]{section.11.4}{Teknologiens effekt i forhold til omkostninger}{chapter.11}% 92
\BOOKMARK [2][-]{subsection.11.4.1}{Omkostninger ved implementering af QST}{section.11.4}% 93
\BOOKMARK [2][-]{subsection.11.4.2}{\330konomisk effekt ved implementering af QST}{section.11.4}% 94
\BOOKMARK [1][-]{section.11.5}{Ressourceudnyttelse}{chapter.11}% 95
\BOOKMARK [2][-]{subsection.11.5.1}{P\345virkning af Region Nordjyllands budget}{section.11.5}% 96
\BOOKMARK [2][-]{subsection.11.5.2}{Transferabilitet}{section.11.5}% 97
\BOOKMARK [1][-]{section.11.6}{Delkonklusion}{chapter.11}% 98
\BOOKMARK [0][-]{chapter.12}{Syntese}{}% 99
\BOOKMARK [1][-]{section.12.1}{Diskussion}{chapter.12}% 100
\BOOKMARK [1][-]{section.12.2}{Konklusion}{chapter.12}% 101
\BOOKMARK [1][-]{section.12.3}{Perspektivering}{chapter.12}% 102
\BOOKMARK [2][-]{subsection.12.3.1}{Kroniske smertepatienter}{section.12.3}% 103
\BOOKMARK [2][-]{subsection.12.3.2}{Forl\370b for patienter med positiv QST-unders\370gelse}{section.12.3}% 104
\BOOKMARK [2][-]{subsection.12.3.3}{Videre forskning}{section.12.3}% 105
\BOOKMARK [0][-]{section*.43}{Litteratur}{}% 106
\BOOKMARK [0][-]{chapter.A}{Appendiks: Borgerforl\370b}{}% 107
\BOOKMARK [0][-]{chapter.B}{S\370geprotokol}{}% 108
\BOOKMARK [1][-]{section.B.1}{TEC}{chapter.B}% 109
\BOOKMARK [1][-]{section.B.2}{EFF}{chapter.B}% 110
\BOOKMARK [1][-]{section.B.3}{SAF}{chapter.B}% 111
\BOOKMARK [1][-]{section.B.4}{ORG}{chapter.B}% 112
\BOOKMARK [1][-]{section.B.5}{SOC}{chapter.B}% 113
\BOOKMARK [1][-]{section.B.6}{ETH}{chapter.B}% 114
\BOOKMARK [1][-]{section.B.7}{ECO}{chapter.B}% 115
